Refinitiv has once again named Goodwin the number one global advisor for Venture Capital and Private Equity Rounds and Venture Capital Rounds by deal count in its H1 2021 Global Venture Capital and Private Equity Legal Advisory League Tables. Goodwin led all law firms by advising firms and companies in 529 total rounds in the first half of the year, which is 47% more rounds than its next closest competitor.
Building upon this success, Mergermarket’s Deal Drivers Americas Report for H1 2021 has named Goodwin the number one firm by deal count for Pharma, Medical & Biotech M&A in North America. Additionally, Pitchbook’s Global League Tables for Q2 2021 demonstrated significant growth, as Goodwin was named the number one advisor in the world for Venture Capital Exits and for completing deals in the Healthcare Devices & Supplies sector (by deal count).
These results demonstrate the unparalleled strength and resiliency of Goodwin’s capital-meets-innovation platform. The firm’s global, collaborative team of Venture Capital, Private Equity and Corporate M&A lawyers continue to help innovators and investors around the world expertly navigate the evolving business landscape and transform the Technology, Healthcare and Life Sciences sectors.
Goodwin’s standout H1/Q2 2021 league tables results include:
Refinitiv Global Legal Advisory League Tables H1 2021 (Deal Count)
- #1 Advisor to Company – All Rounds (Private Equity and Venture Capital)
- #1 Advisor to Firm – All Rounds (Private Equity and Venture Capital)
- #1 Advisor to Firm – Venture Capital Rounds
- #2 Advisor to Company – Venture Capital Rounds
- #3 Advisor to Company – LBO & Related Rounds
Mergermarket Deal Drivers Americas H1 2021 (Deal Count)
- #1 Pharma, Medical & Biotech M&A
- #3 Technology, Media & Telecom M&A
Pitchbook Global League Tables Q2 2021 (Deal Count)
- #1 Venture Capital Exits
- #1 Venture Capital Deals – Healthcare Devices & Supplies
- #3 U.S. Venture Capital Deals
- #3 Global Venture Capital Deals
- #3 Europe Venture Capital Deals
- #3 U.S. Venture Capital, Private Equity & M&A Deals
- #3 Global Venture Capital, Private Equity & M&A Deals
- #3 Global Venture Capital Deals – Early-Stage
- #3 Global Venture Capital Deals – Late-Stage